1. Home
  2. IRON vs KN Comparison

IRON vs KN Comparison

Compare IRON & KN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Disc Medicine Inc.

IRON

Disc Medicine Inc.

HOLD

Current Price

$69.83

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Logo Knowles Corporation

KN

Knowles Corporation

HOLD

Current Price

$40.33

Market Cap

3.0B

ML Signal

HOLD

Company Overview

Basic Information
Metric
IRON
KN
Founded
2017
1946
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Consumer Electronics/Appliances
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
3.0B
IPO Year
2020
2013

Fundamental Metrics

Financial Performance
Metric
IRON
KN
Price
$69.83
$40.33
Analyst Decision
Strong Buy
Buy
Analyst Count
11
3
Target Price
$103.18
$28.00
AVG Volume (30 Days)
384.6K
928.9K
Earning Date
05-07-2026
04-23-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
118.94
EPS
N/A
0.11
Revenue
N/A
$593,200,000.00
Revenue This Year
N/A
$9.40
Revenue Next Year
$283.52
$6.98
P/E Ratio
N/A
$376.09
Revenue Growth
N/A
7.17
52 Week Low
$40.00
$16.94
52 Week High
$99.50
$41.47

Technical Indicators

Market Signals
Indicator
IRON
KN
Relative Strength Index (RSI) 54.12 65.53
Support Level $64.48 $23.97
Resistance Level $71.85 N/A
Average True Range (ATR) 3.26 1.70
MACD 0.04 0.07
Stochastic Oscillator 64.61 73.32

Price Performance

Historical Comparison
IRON
KN

About IRON Disc Medicine Inc.

Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs), including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.

About KN Knowles Corporation

Knowles Corp is engaged in the manufacturing of micro-acoustic microphones and balanced armature speakers, audio solutions, high-performance capacitors, and radio frequency filtering products. It operates in two segments; the Precision Devices segment specializes in the design and delivery of high-performance capacitor products and RF solutions; and Medtech & Specialty Audio segment designs and manufactures microphones and balanced armature speakers used in applications. The majority of its revenue comes from the Precision Devices. Geographically, it operates in United States, Asia, Other Americas, Europe and Others, out of which United States generates maximum revenue.

Share on Social Networks: